Investors

Committee Composition

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.

	Audit Committee	Compensation Committee	Nominating and Corporate Governance Committee
David Bonita	Audit Committee	Compensation Committee
Mardi Dier	Audit Committee	Compensation Committee
Paul Friedman	Audit Committee		Nominating and Corporate Governance Committee
Julian Baker		Compensation Committee	Nominating and Corporate Governance Committee
Victor Sandor			Nominating and Corporate Governance Committee

= Chairperson = Member = Chairman of the Board

Print Page

RSS Feeds

Email Alerts